Analyst Ratings for Gentiva Health Services (gtiv)

gtiv Rating Summary

gtiv Price Target Summary

  |   Expand Research on gtiv
Overall Rating: NEUTRAL   Rating Trend: Up   Avg. $ Target: $8.88 (-9.9%)
Date Firm Type Rating
(Past)
PT
(Past)
Start $ End $ % Chg. Details
2/21/2013 Raymond James Upgrade Underperform
(Market Perform)
N/A
(N/A)
11.55 9.85 -14.72% Details
7/26/2012 Deutsche Bank Upgrade Buy
(Hold)
12.50
(8.00)
6.94 9.85 41.93% Details
5/15/2012 Baird Upgrade Neutral
(N/A)
6.00
(N/A)
6.37 9.85 54.63% Details
3/15/2012 Piper Jaffray New Coverage Overweight
(N/A)
10.00
(N/A)
7.84 9.85 25.64% Details
11/14/2011 Stephens Downgrade Equal Weight
(N/A)
N/A
(N/A)
5.43 9.85 81.4% Details
10/5/2011 BB&T Capital Downgrade Hold
(N/A)
N/A
(N/A)
3.02 9.85 226.16% Details
7/19/2011 Jefferies
» Updated 1/20/2012
Downgrade Hold
(N/A)
7.00
(N/A)
18.46 9.85 -46.64% Details
5/24/2011 FBR Capital Upgrade Market Perform
(N/A)
N/A
(N/A)
23.91 9.85 -58.8% Details
1/12/2011 Stifel Nicolaus Downgrade Hold
(N/A)
N/A
(N/A)
26.31 9.85 -62.56% Details
Like gtiv Ratings? Also take a look at LHCG, AMED

gtiv Ratings News